Search

everythinglearnresearchcommunity

for

Search:↓

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

Sexual orientation does not affect the prevalence of PCOS or fertility rates in women undergoing artificial donor insemination.

Healthcare providers need better education and policies to serve transgender individuals effectively.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

Women with greater androgen sensitivity respond better to finasteride for hair loss.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Multiphoton microscopy can effectively assess breast cancer treatment responses without labels.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

Androgen receptor inactivation delays skin cancer onset and reduces incidence in mice, with gender differences in susceptibility.

The conclusion is that a thorough approach is needed to diagnose and manage hyperandrogenism in teenage girls, recognizing its major psychological and health effects.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Blocking 5α-reductase can harm memory and brain structure, and increase harmful brain changes in male mice used for Alzheimer's disease research.

Chemotherapy causes complex changes in hair follicle cells that can lead to hair loss.

Low intensity ultrasound may reduce side effects of chemotherapy drugs like paclitaxel.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

The conclusion is that there is a high demand for new contraceptives that provide both pregnancy prevention and protection against STIs, along with additional health benefits.

A new non-invasive method can analyze skin mRNA to understand skin diseases better.

The conclusion is that more research is needed to better understand and treat adult acne, and that patient education and simple treatment plans are important for better results.

PCOS is a long-term condition that needs more research for better understanding and treatment.

Low birthweight and rapid weight gain after birth may increase the risk of developing polycystic ovary syndrome.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Different types of fibroblasts play various roles in kidney repair and aging, and may affect chronic kidney disease outcomes.

Taxol damages hair growth cells, causing hair loss.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Exosomes from umbilical cord cells fix hearing loss and damaged ear hair cells in mice.

Early diagnosis and treatment, like topical minoxidil, can prevent hair loss in children.